Hypnosis to help adolescents and young adults cope with cancer and chemotherapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

HYPNO-AJA 2 is a single-center interventional study at Institut Bergonié to see if hypnosis can ease anxiety and chemotherapy-related symptoms in adolescents and young adults with sarcoma or germ cell tumors and in young women with breast cancer receiving neoadjuvant chemotherapy. The trial focuses on feasibility, safety, and potential therapeutic value of hypnosis as an adjunct to standard cancer care. Eligible participants are aged 15-39 (AYAs) with specified cancers or 15-49 for breast cancer, undergoing initial treatment with anthracyclines and/or alkylating agents. Interventions are delivered in a hospital or day-hospital setting and require informed consent. Outcomes include patient-reported emotional and physical symptoms during treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Newly diagnosed patients receiving initial care and follow-up at the Institut Bergonié during treatment:

   1. Adolescents or young adults (AJA) aged 15 to 39 with soft tissue or bone sarcoma or a germ cell tumor (testicular, ovarian),
   2. Young women aged 15 to 49 with breast cancer.
2. Treatment with neoadjuvant chemotherapy based on anthracyclines and/or alkylating agents.
3. Treatment administered as:

   1. Inpatient for patients with soft tissue or bone sarcoma or a germ cell tumor (testicular, ovarian),
   2. Outpatient or day hospital for female patients with breast cancer.
4. Dated and signed informed consent (if the patient is a minor, consent must also be signed by the legal guardians).
5. Patient enrolled in a social security program in accordance with current regulations.

Exclusion Criteria:

1. Known contraindications to hypnosis (psychotic disorders, mental disorders, confusion, deafness, severe cognitive impairment, etc.)
2. Patients who have already undergone hypnosis sessions within 6 months prior to enrollment.
3. Geographic, social, or psychological factors rendering the patient unable to comply with the study's follow-up and procedures.
4. Patients who are deprived of their liberty or subject to a legal protection measure (guardianship, conservatorship, judicial protection, or family authorization).

Where it's running

• Institut Bergonie
  Bordeaux, France Recruiting

Study contacts

• Study coordinator: Caroline LALET, Project manager
• Email: c.lalet@bordeaux.unicancer.fr
• Phone: +33556333347

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Clonal Hematopoiesis Effects with Chemo and Radiation in Solid Cancers

  This study tests whether clonal hematopoiesis affects outcomes for adults with solid cancers who are receiving chemotherapy or radiation.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07675967

• LRRC15-targeted PET imaging for more precise diagnosis and staging of pancreatic, breast, lung, sarcoma and head-and-neck cancers

  This project tests whether an LRRC15-targeted PET scan can better detect and stage LRRC15-expressing cancers and measures how the tracer behaves in healthy adults.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07552467

• Safety and dosing of 177Lu-INN805 in patients with malignant solid tumors

  This early-phase, single-arm study tests different dose levels of 177Lu-INN805 to see if it can be safely given and if it shows signs of activity in adults with hard-to-treat solid tumors.

  Recruiting Early Phase 1 FindCure Biosciences (ZhongShan) Co., Ltd. · Wuxi, Jiangsu · NCT07459283

• Riluzole to prevent thinking and memory problems during chemotherapy

  This pilot trial tests whether riluzole can prevent thinking and memory problems in adults with cancer receiving anthracycline- or platinum-based chemotherapy.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT07447050

• Navigation program for young cancer survivors

  This project tests an adapted navigation program to help adolescent and young adult cancer survivors get timely care within Kaiser Permanente Southern California.

  Recruiting Kaiser Permanente · Pasadena, California · NCT07406087

• Virtual exercise program to preserve function and prevent disability during chemotherapy

  This trial tests whether supervised resistance sessions by video plus short home aerobic workouts help adults 18–64 maintain strength and stay active while receiving curative-intent chemotherapy.

  Recruiting at 29 sites Alliance for Clinical Trials in Oncology · Dublin, California and 29 other locations · NCT07059884

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.